[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT06593405":3,"trial-entities:NCT06593405":93,"trial-summary:NCT06593405":98},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":20,"study_type":21,"primary_purpose":22,"phases":23,"enrollment_info":25,"interventions":28,"primary_outcomes":35,"secondary_outcomes":44,"sex":45,"minimum_age":46,"maximum_age":47,"healthy_volunteers":48,"eligibility_criteria":49,"std_ages":57,"locations":60,"central_contacts":79,"overall_officials":82,"references":84,"see_also_links":89},"NCT06593405","IRB-2023-2024-84","The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, DR and Glaucoma","The Role of Occupational Therapy for Improving Medication Management for Persons With AMD, Diabetic Retinopathy (DR) and Glaucoma","RECRUITING","2026-12-05","2026-05","2026-05-12","2025-04-22","MCPHS University","OTHER",false,"The goal of this clinical trial is to learn if education about additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies will improve medication management skills. The main questions it aims to answer are:\n\nDoes additional task lighting, enhanced contrast, enlarged print instructions, smart apps and organizational strategies improve medication management skills, reduce errors and improve functional use of remaining vision for this task?\n\nParticipants will:\n\nOftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills.","Many clients with low vision are unaware of OT, or the services OT can provide to assist with low vision needs. Clients with AMD, DR or Glaucoma who choose to receive the one hour OT service will be provided with 1:1 education regarding the devices and strategies that may improve their ability to perform medication management skills. Clients will complete the MediCog and the Revised-Self-Report Assessment of Functional Visual Performance (R-SRAFVP) assessment tools with the assistance of the OT. These tools will inform the therapist to areas of client needs and allow for focus on intervention to support these challenges. Follow up in OT 4 weeks post intervention will allow therapist to reassess the effectiveness of interventions provided via a phone or in-person interview as well as provide the assessments again. Second set of data from these assessments will be compared to initial findings obtained.",[19],"Age-Related Macular Degeneration",[],"INTERVENTIONAL","TREATMENT",[24],"EARLY_PHASE1",{"count":26,"type":27},50,"ESTIMATED",[29],{"type":30,"name":31,"description":32,"armGroupLabels":33},"COMBINATION_PRODUCT","occupational therapy interventions for low vision care","Occupational therapists utilize many different treatment strategies when caring for the client with low vision. Oftentimes, the client is unaware of these strategies which may improve occupational performance during a valued activity. Interventions include task lighting, organizational strategies, smart apps, contrast, enlarged print, typoscopes and electronic magnification devices.",[34],"Receiving OT interventions",[36,40],{"measure":37,"description":38,"timeFrame":39},"Revised Self Report Assessment of Functional Visual","A standardized assessment which provides information on how well adults with vision loss can perform daily tasks. This tool has 33 assessment components and a higher score indicates less functional impairment. A lower score indicates a higher impairment.","Results from the Revised-Self-Report Assessment of Functional Visual Performance assessment will be determined on day 1 and 4 weeks later",{"measure":41,"description":42,"timeFrame":43},"MediCog Screening Tool","The Medi-Cog has a maximum score of 10 points, and a score of 7 or lower may indicate cognitive impairment.","Results from the MediCog will be determined on day 1 and will be obtained 4 weeks later",[],"ALL","50 Years","100 Years",true,{"inclusion":50,"exclusion":53,"raw_text":56},[51,52],"Clients with AMD, DR or Glaucoma","Clients who choose to participate will allow their deidentified data to be evaluated for outcomes.",[54,55],"Clients with other age related eye diseases other than AMD, DR or Glaucoma.","Clients who do not wish to participate in this study.","Inclusion Criteria:\n\n* Clients with AMD, DR or Glaucoma\n* Clients who choose to participate will allow their deidentified data to be evaluated for outcomes.\n\nExclusion Criteria:\n\n* Clients with other age related eye diseases other than AMD, DR or Glaucoma.\n* Clients who do not wish to participate in this study.",[58,59],"ADULT","OLDER_ADULT",[61],{"facility":62,"status":8,"city":63,"state":64,"zip":65,"country":66,"contacts":67,"geoPoint":76},"MCPHS 10 Lincoln Square","Worcester","Massachusetts","01608","United States",[68,73],{"name":69,"role":70,"phone":71,"email":72},"Michelle Dowling, Clinical Doctorate (OTD)","CONTACT","508-373-5851","michelle.dowling@mcphs.edu",{"name":74,"role":75},"Michelle Dowling, Clinical Doctorate","PRINCIPAL_INVESTIGATOR",{"lat":77,"lon":78},42.26259,-71.80229,[80],{"name":81,"role":70,"phone":71,"email":72},"Michelle Dowling, OTD",[83],{"name":81,"affiliation":13,"role":75},[85],{"pmid":86,"type":87,"citation":88},"29309002","BACKGROUND","Occupational Therapy's Role in Medication Management. Am J Occup Ther. 2017 Nov\u002FDec;71(Supplement_2):7112410025p1-7112410025p20. doi: 10.5014\u002Fajot.2017.716S02. No abstract available.",[90],{"label":91,"url":92},"American Occupational Therapy Association link to professional information","https:\u002F\u002Fwww.aota.org\u002Fpublications\u002Fot-practice\u002Fot-practice-issues\u002F2020\u002Fmedication-adherence",{"nct_id":4,"conditions":94,"biomarkers":97},[19,95,96],"Diabetic Retinopathy","Glaucoma",[],{"nct_id":4,"found":48,"summary":99,"prompt_version":109},{"design":100,"status":101,"heading":102,"summary":103,"follow_up":104,"word_count":105,"commitments":106,"compensation":107,"drugs_mentioned":108},"This interventional study plans to enroll 50 participants. It is not specified if the study is randomized or blinded.","completed","Occupational Therapy for Medication Management in Low Vision","This study is exploring if occupational therapy (OT) interventions can help people with Age-Related Macular Degeneration (AMD), Diabetic Retinopathy (DR), or Glaucoma manage their medications better. These interventions include education on using additional task lighting, enhanced contrast, enlarged print instructions, smart apps, and organizational strategies. The researchers want to see if these strategies improve medication management skills, reduce errors, and help you use your remaining vision more effectively for this task. They will measure success by looking at your self-reported ability to perform daily activities and your medication management skills. The study aims to enroll 50 participants aged 50 to 100 years old, of all genders. The current recruitment status is unclear.","Participants will be followed up 4 weeks after the initial intervention.",112,"You will receive a one-hour occupational therapy service and complete two assessment tools with the therapist. A follow-up interview will occur 4 weeks later.","Not stated in the trial record.",[],"v2"]